| __timestamp | Geron Corporation | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20707000 | 581800000 |
| Thursday, January 1, 2015 | 17831000 | 671900000 |
| Friday, January 1, 2016 | 18047000 | 876700000 |
| Sunday, January 1, 2017 | 11033000 | 857900000 |
| Monday, January 1, 2018 | 13432000 | 822200000 |
| Tuesday, January 1, 2019 | 52072000 | 778200000 |
| Wednesday, January 1, 2020 | 51488000 | 512600000 |
| Friday, January 1, 2021 | 85727000 | 681000000 |
| Saturday, January 1, 2022 | 95518000 | 662200000 |
| Sunday, January 1, 2023 | 125046000 | 910700000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, strategic investment in research and development (R&D) is crucial. Over the past decade, Viatris Inc. and Geron Corporation have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, Viatris consistently allocated a significant portion of its resources to R&D, with expenditures peaking at approximately $910 million in 2023. This represents a steady increase of around 56% from 2014. In contrast, Geron Corporation's R&D spending, while more modest, surged by nearly 500% over the same period, reaching about $125 million in 2023. This dramatic rise underscores Geron's commitment to innovation, despite its smaller scale. These trends highlight the diverse strategies companies employ to maintain competitive edges and drive future growth in the ever-evolving pharmaceutical industry.
R&D Insights: How Sanofi and Geron Corporation Allocate Funds
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
Research and Development: Comparing Key Metrics for Incyte Corporation and Geron Corporation
Research and Development Investment: Viatris Inc. vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Viatris Inc. and HUTCHMED (China) Limited
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Analyzing R&D Budgets: CRISPR Therapeutics AG vs Geron Corporation
Research and Development Expenses Breakdown: Amicus Therapeutics, Inc. vs Geron Corporation
Analyzing R&D Budgets: HUTCHMED (China) Limited vs Geron Corporation